Re:Carcinogens Have Infiltrated the Generic Drug Supply in t...
by mirimir on Saturday September 14, 2019 @01:29AM
(#20969099)
That's no inflation adjusted. And it's also not adjusted for processing load. But it does show the greatly increased role of user fees, which I gather has facilitated regulatory capture.
Re:Carcinogens Have Infiltrated the Generic Drug Supply in t...
by refurb on Saturday September 14, 2019 @02:04AM
(#20969191)
Inflation hasn’t been 600% since 1992.
Not sure what processing load is, but if they’re asked to do more that could be an issue, but I wouldn’t call it a cut.
Re:Carcinogens Have Infiltrated the Generic Drug Supply in t...
by mirimir on Saturday September 14, 2019 @02:06PM
(#20972595)
I do remember reading about cuts in FDA resources. As an excuse for why they'd missed so many violations.
Checking, I see that it was Reagan era cuts.[0] So the timeline that you cited begins in 1992, which was probably the minimum funding level.[1,2]
Also, Hatch-Waxman was approved in 1984, which increased the workload considerably. And then there was the first generic drug scandal in the late 80s. That's what I was thinking of.
0) https://academic.oup.com/shm/article-abstract/29/1/202/24722...
1) https://www.everycrsreport.com/reports/R44576.html#_Toc82198...
What do you mean downsized?
[1]https://www.everycrsreport.com/reports/R44576.html#_Toc82198...